chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Disturbance in attention, Dysphonia, Facial pain, Hypoaesthesia
Clinical narrative: 20 minutes after receiving the the the back of my head starting burning then the whole left side of my head; Whole left side of the face started hurting; Face started hurting and went numb; My sinuses on the left side felt swollen and inflamed; Trouble talking; Couldn't concentrate; A few hours later the tops of my feet swelled up; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 12:15 (at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history included GERD (gastroesophageal reflux disease). Concomitant medications included rabeprazole (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. On 09Apr2021 at 12:45, 20 minutes after receiving, the patient's back of the head starting burning, then the whole left side of the head and face started hurting and went numb. The patient's sinuses on the left side felt swollen and inflamed, had trouble talking and couldn't concentrate. A few hours later, the tops of the feet swelled up. Even after almost 24 hours, the head still didn't feel normal, left side of the head still didn't feel right and sinuses on left side were still inflamed. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events back of the head starting burning, whole left side of the head and face started hurting and went numb, sinuses on the left side felt swollen and inflamed, had trouble talking and couldn't concentrate, the tops of the feet swelled up was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Peripheral swelling
Clinical narrative: 20 minutes after receiving the the the back of my head starting burning then the whole left side of my head; Whole left side of the face started hurting; Face started hurting and went numb; My sinuses on the left side felt swollen and inflamed; Trouble talking; Couldn't concentrate; A few hours later the tops of my feet swelled up; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 12:15 (at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history included GERD (gastroesophageal reflux disease). Concomitant medications included rabeprazole (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. On 09Apr2021 at 12:45, 20 minutes after receiving, the patient's back of the head starting burning, then the whole left side of the head and face started hurting and went numb. The patient's sinuses on the left side felt swollen and inflamed, had trouble talking and couldn't concentrate. A few hours later, the tops of the feet swelled up. Even after almost 24 hours, the head still didn't feel normal, left side of the head still didn't feel right and sinuses on left side were still inflamed. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events back of the head starting burning, whole left side of the head and face started hurting and went numb, sinuses on the left side felt swollen and inflamed, had trouble talking and couldn't concentrate, the tops of the feet swelled up was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Hive/Rash cluster on right hip, left forearm, right ear and left cheek below eye.; Hive/Rash cluster on right hip, left forearm, right ear and left cheek below eye.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the left arm on 03Apr2021 at 10:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included TB when the patient was 17 and allergy to molds and pollen allergy. Concomitant medications included thioctic acid (ALPHA LIPOIC ACID) and multivitamin (MANUFACTURER UNKNOWN), both for unknown indications from unknown dates. The patient previously received vicodin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced hive/rash cluster on right hip, left forearm, right ear and left cheek below eye. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events hive/rash cluster on right hip, left forearm, right ear and left cheek below eyes was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Confusional state, Menstruation irregular, Migraine
Clinical narrative: Menstrual bleeding  (after no period in8 years due to continuous cycling); Aches/pain; Abdominal pain; Migraine; Fever; Chills; Nausea; Confusion; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 18:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient was allergic to latex, egg protein and casein. Concomitant medications included buspirone hydrochloride (BUSPAR), oral contraceptives nos (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 09:00, the patient experienced menstrual bleeding (after no period in 8 years due to continuous cycling), aches/pain, abdominal pain, migraine, fever, chills, nausea and confusion. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events menstrual bleeding, aches/pain, abdominal pain, migraine, fever, chills, nausea and confusion were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Menstrual bleeding  (after no period in8 years due to continuous cycling); Aches/pain; Abdominal pain; Migraine; Fever; Chills; Nausea; Confusion; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 18:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient was allergic to latex, egg protein and casein. Concomitant medications included buspirone hydrochloride (BUSPAR), oral contraceptives nos (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 09:00, the patient experienced menstrual bleeding (after no period in 8 years due to continuous cycling), aches/pain, abdominal pain, migraine, fever, chills, nausea and confusion. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events menstrual bleeding, aches/pain, abdominal pain, migraine, fever, chills, nausea and confusion were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain of skin
Clinical narrative: Skin pain; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 04Apr2021 at 12:45 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient received pantoprazole 40 mg (MANUFACTURER UNKNOWN) for unspecified indication and from unknown start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021, the patient experienced skin pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event skin pain was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Pruritus, Rash
Clinical narrative: Skin allergy; "bad rash all over body"; "Itchiness all over body"; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 22:00, the patient experienced skin allergy, a bad rash all over body and itchiness all over body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events skin allergy, "bad rash all over body" and "itchiness all over body" were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Speech disorder
Clinical narrative: Skin allergy; "bad rash all over body"; "Itchiness all over body"; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 22:00, the patient experienced skin allergy, a bad rash all over body and itchiness all over body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events skin allergy, "bad rash all over body" and "itchiness all over body" were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity
Clinical narrative: I went to sit down, when I got a warm metallic taste in my mouth. It was intense at first, the continued until last night. I still have some metallic taste in my mouth, but not near as strong.; Arm is sore; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration in the left arm on 09Apr2021 at 14:15 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, anxiety, allergies, asthma, high cholesterol, high eye pressures, allergy to animals (dogs and cats) and dust mites allergy. The patient received unspecified medications within two weeks of vaccination. The patient previously took erythromycin (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 14:15, after receiving the vaccination, the patient went to sit down, when she got a warm metallic taste in her mouth. It was intense at first, the continued until last night. The patient still have some metallic taste in the mouth, but not near as strong.  It felt like when she gets an injection in her mouth at the dentist, that kind of feeling. Other than that, the arm was sore. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events "went to sit down, when got a warm metallic taste in my mouth, it was intense at first, the continued until last night, still have some metallic taste in my mouth, but not near as strong, it felt like when I get an injection in my mouth at the dentist, that kind of feeling" and arm is sore were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pain
Clinical narrative: chills; sweats; fatigue; headache; dry heaves; fever; soreness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 13:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 18:45 the patient experienced chills, sweats, fatigue, headache, dry heaves, fever, soreness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, sweats, fatigue, headache, dry heaves, fever, soreness was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Retching
Clinical narrative: chills; sweats; fatigue; headache; dry heaves; fever; soreness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 13:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 18:45 the patient experienced chills, sweats, fatigue, headache, dry heaves, fever, soreness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, sweats, fatigue, headache, dry heaves, fever, soreness was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Cough, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Developed a cough approximately three days after shot; Had intense pain in feet and ankles; Felt like bones were breaking when I walked; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 12Mar2021 at 10:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included high cholesterol, hypothyroidism, mild osteopenia, depression and shellfish allergy. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and calcium gluconate (CALCIUM); all from unknown dates for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 08:00, approximately three days after shot, the patient developed a cough, had intense pain in feet and ankles for three days straight. The patient felt like bones were breaking when walked. Subsided gradually but still had a little pain three weeks later. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 29Mar2021, the patient underwent SARS-CoV-2 test and the result was negative. The clinical outcome of the events cough, intense pain in feet and ankles for three days and felt like bones were breaking when walked were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Lymphadenopathy, Oropharyngeal pain, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Red, raised, itchy, hot circle the size of a tennis ball below injection; Red, raised, itchy, hot circle the size of a tennis ball below injection; Red, raised, itchy, hot circle the size of a tennis ball below injection; Throat glands are swollen; Throat is sore; Swallowing is uncomfortable; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 06Apr2021 at 13:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy and the patient had no other relevant medical history. Concomitant medications included guaifenesin, dextromethorphan hydrobromide (MUCINEX DM) tablet, taken from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 12:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, three days after the second vaccination, the patient experienced red, raised, itchy, hot circle the size of a tennis ball below injection. On the same day, the patient also experienced throat glands swollen, throat was sore and swallowing was uncomfortable. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events red, raised, itchy, hot circle the size of a tennis ball below injection, throat glands swollen, throat was sore and swallowing was uncomfortable were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Red, raised, itchy, hot circle the size of a tennis ball below injection; Red, raised, itchy, hot circle the size of a tennis ball below injection; Red, raised, itchy, hot circle the size of a tennis ball below injection; Throat glands are swollen; Throat is sore; Swallowing is uncomfortable; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 06Apr2021 at 13:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy and the patient had no other relevant medical history. Concomitant medications included guaifenesin, dextromethorphan hydrobromide (MUCINEX DM) tablet, taken from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 12:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, three days after the second vaccination, the patient experienced red, raised, itchy, hot circle the size of a tennis ball below injection. On the same day, the patient also experienced throat glands swollen, throat was sore and swallowing was uncomfortable. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events red, raised, itchy, hot circle the size of a tennis ball below injection, throat glands swollen, throat was sore and swallowing was uncomfortable were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cold sweat, Headache, Nausea, Pain in extremity
Clinical narrative: cold sweats; Weak; sore arm; nausea; headache; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included and concomitant medications were not reported. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) in the left arm on 18Mar2021 at 15:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced weak, cold sweats, sore arm, nausea and headache. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event weak, cold sweats, sore arm, nausea and headache was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Neck pain, Pain in extremity
Clinical narrative: Woke up with muscle pain in both legs & neck area. Fatigue & headache. The worse part was leg muscle pain. Felt exactly like the reaction I had the day after my 2nd Pfizer shot. But this is 17 days af; Woke up with muscle pain in both legs & neck area. Fatigue & headache. The worse part was leg muscle pain. Felt exactly like the reaction I had the day after my 2nd Pfizer shot. But this is 17 days af; Woke up with muscle pain in both legs & neck area. Fatigue & headache. The worse part was leg muscle pain. Felt exactly like the reaction I had the day after my 2nd Pfizer shot. But this is 17 days af; Woke up with muscle pain in both legs & neck area. Fatigue & headache. The worse part was leg muscle pain. Felt exactly like the reaction I had the day after my 2nd Pfizer shot. But this is 17 days af; Woke up with muscle pain in both legs & neck area. Fatigue & headache. The worse part was leg muscle pain. Felt exactly like the reaction I had the day after my 2nd Pfizer shot. But this is 17 days af; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included back pain, high cholesterol and elevated BP. Concomitant medications included acetylsalicylic acid (ASA), metoprolol (MANUFACTURER UNKNOWN), curcuma longa rhizome (TUMERIC), fish oil (MANUFACTURER UNKNOWN) and GEN LIPITOR. The patient previously took codeine and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 02Mar2021 (at the age of 66-year-old) as a single dose for COVID-19 immunisation Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 10Apr2021 at 04:00 (after 17 days) the patient woke up with the muscle pain in both legs & neck area, fatigue and headache. The worse part was leg muscle pain. The patient also reports that she felt exactly like the reaction she had the day after her 2nd Pfizer shot and that was on 25Mar2021. The patient also reports that this was 17 days after the second dose and she was not sure if the above events were related to vaccine or not. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events muscle pain in both legs & neck area, fatigue and headache were recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth injury, Oral mucosal eruption
Clinical narrative: Oral rashes; Feeling of cut in the mouth; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 25Mar2021 at 12:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies. Concomitant medications included bisoprolol fumarate (CONCOR) taken for hypertension. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 13:00, the patient experienced oral rashes and had feeling of cut in the mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events oral rashes and feeling of cut in the mouth were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia, Vaccination site erythema, Vaccination site mass
Clinical narrative: The next morning after my 2nd vaccine, I had a hard lump, redness & soreness at injection site.; The next morning after my 2nd vaccine, I had a hard lump, redness & soreness at injection site.; The next morning after my 2nd vaccine, I had a hard lump, redness & soreness at injection site.; a headache began by noon; 2 short-lasting episodes of light dizziness w/o complications.; Also had all over muscle aches; This is a spontaneous report from a contactable other healthcare professional. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6200) via an unspecified route of administration in the right arm on 18Feb2021 at 17:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to adhesives. Concomitant medications included glucosamine sulfate (GLUCOSAMINE), ferropolichondrum (CHONDROITIN), herbal turmeric and vitamins, all from unspecified dates and  for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5318) via an unspecified route of administration in the right arm in Jan2021 at 17:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient also received previously erythromycin(MANUFACTURER UNKNOWN) on an unknown date and experienced allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021 at 07:00, the patient experienced a hard lump, redness and soreness at injection site(vaccination site). On 19Feb2021 in the noon, the patient had muscle aches all over, a headache and 2 short-lasting episodes of light dizziness without (w/o) complications. The patient did not receive any treatment for the reported events. The clinical outcome of the events hard lump, redness and soreness at injection site, muscle aches, headache and dizziness were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: The next morning after my 2nd vaccine, I had a hard lump, redness & soreness at injection site.; The next morning after my 2nd vaccine, I had a hard lump, redness & soreness at injection site.; The next morning after my 2nd vaccine, I had a hard lump, redness & soreness at injection site.; a headache began by noon; 2 short-lasting episodes of light dizziness w/o complications.; Also had all over muscle aches; This is a spontaneous report from a contactable other healthcare professional. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6200) via an unspecified route of administration in the right arm on 18Feb2021 at 17:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to adhesives. Concomitant medications included glucosamine sulfate (GLUCOSAMINE), ferropolichondrum (CHONDROITIN), herbal turmeric and vitamins, all from unspecified dates and  for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5318) via an unspecified route of administration in the right arm in Jan2021 at 17:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient also received previously erythromycin(MANUFACTURER UNKNOWN) on an unknown date and experienced allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021 at 07:00, the patient experienced a hard lump, redness and soreness at injection site(vaccination site). On 19Feb2021 in the noon, the patient had muscle aches all over, a headache and 2 short-lasting episodes of light dizziness without (w/o) complications. The patient did not receive any treatment for the reported events. The clinical outcome of the events hard lump, redness and soreness at injection site, muscle aches, headache and dizziness were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Diarrhoea, Dizziness, Lymphadenopathy
Clinical narrative: brain fog; dizziness; diarrhea; swollen lymph nodes especially arm pit and neck of theinjection arm; nausea; fever; severe joint pain; Swelling at injection site(covid arm); Rash at injection site(covid arm); This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. The patient did not receive any other medications within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 15Mar2021 at 09:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 21:00, the patient experienced swelling and rash at injection site (COVID arm), swollen lymph nodes especially in arm pit and neck of the injection arm, fever, severe joint pain, nausea, diarrhea, brain fog and dizziness. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling at injection site, rash at injection site, swollen lymph nodes in arm pit and neck of the injection arm, fever, severe joint pain, nausea, diarrhea, brain fog and dizziness was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site rash, Vaccination site swelling
Clinical narrative: brain fog; dizziness; diarrhea; swollen lymph nodes especially arm pit and neck of theinjection arm; nausea; fever; severe joint pain; Swelling at injection site(covid arm); Rash at injection site(covid arm); This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. The patient did not receive any other medications within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 15Mar2021 at 09:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 21:00, the patient experienced swelling and rash at injection site (COVID arm), swollen lymph nodes especially in arm pit and neck of the injection arm, fever, severe joint pain, nausea, diarrhea, brain fog and dizziness. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling at injection site, rash at injection site, swollen lymph nodes in arm pit and neck of the injection arm, fever, severe joint pain, nausea, diarrhea, brain fog and dizziness was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Pain
Clinical narrative: Body aches; Fatigue; Feeling cold occurred about 2 weeks after 2nd shot and again last night (4/9/21). Symptoms disappeared by next day; This is a spontaneous report from a contactable consumer, the patient. An 81-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 15Mar2021 at 19:30 as a single dose for COVID-19 immunisation. Medical history included bronchiectasis and acid reflux (esophageal). The patient had no known allergies to medications, food or other products. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) and Ipratropium bromide (DUONEB) all for unknown indications, from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 22Feb2021 at 16:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 the patient experienced body aches, fatigue, feeling cold occurred about 2 weeks after 2nd shot and again last night (09Apr2021). Symptoms disappeared by next day. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches, fatigue, feeling cold occurred about 2 weeks after 2nd shot and again last night (09Apr2021) were recovered on unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Fatigue, Pain, Palpitations
Clinical narrative: Light headed/ dizzy; Racing heart; Body pain; Severe metal taste in mouth; Tired for a week.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 17Mar2021 at 11:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of known allergies to penicillin (MANUFACTURER UNKNOWN). The patient received codeine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Concomitant medications included vitamin d nos (VITAMIN D), estradiol (MANUFACTURER UNKNOWN) and duloxetine hydrochloride (CYMBALTA); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021 at 11:00, the patient experienced light headed, dizzy, racing heart, body pain, severe metal taste in mouth that still wouldn't go away and tired for a week. No therapeutic measures were taken for the reported events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tired for a week was recovered on 24Mar2021, while the clinical outcome of the events light headed, dizzy, racing heart, body pain and severe metal taste were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Developed an echo in left ear that had become increasingly louder and the sound is at a slightlyhigher pitch than actual sound; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG 206) via an unspecified route of administration in the arm left on 11Mar2021 at 09:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, arthritis and obesity. It was unknown if the patient had any known allergies. The patient received other medications within two weeks of vaccination, names were unspecified. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Feb2021 at 09:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced an echo in left ear that had become increasingly louder. The sound was at a slightly higher pitch than actual sound. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event an echo in left ear that had become increasingly louder, the sound was at a slightly higher pitch than actual sound was not recovered.  No follow-up attempts are needed. No further information is expected.